Financial calendar

2022

Upcoming events
2022
2021
2020
2019
All years

Financial

Events
All events

February 24, 2022

Year-end report January – December 2021

Investor contact

Cord Communications

IR@oasmia.com

+46 18-50 54 40

Subscribe to our news

Investors

About Us
Our Science
Corporate Governance
Investors
Media
Contact

Oasmia Pharmaceutical AB develops, manufactures, markets and sells an improved generation of drugs within human and veterinary oncology. Product development aims to produce novel formulations of well-established cytostatic agents which show improved performance, an improved side-effect profile and a wider range of therapeutic areas compared with existing alternatives. Product development is based on the proprietary technology platform XR-17.

The Share

Follow the share

Personal data
Cookies

OAS-MA-P-001-SEP2020

Oasmia Pharmaceutical AB
Vallongatan 1, 752 28
Uppsala, Sweden

Tel +46 18 50 54 40
Fax +46 18 51 08 73
info@oasmia.com